Dr. Jonathan Viventi's lab at Duke University focuses on developing advanced technology to help patients with severe speech impairments, such as those caused by ALS or Locked-in Syndrome. The main goal is to create a wireless device that can capture brain signals and translate them into speech, allowing these individuals to communicate more effectively. By using high-density micro-electrocorticographic arrays and machine learning algorithms, the lab aims to transform how technology assists with verbal communication for those who need it most.

Dr. Michelle Louise James's lab at Stanford University focuses on improving cancer immunotherapy, particularly through the development of imaging techniques that can track the activity of specialized T cells used in therapies like CAR T cell treatment. By creating advanced imaging agents, the lab aims to provide doctors with new tools to monitor and optimize these therapies for better patient outcomes. Their work seeks to enhance our understanding of how T cells behave in the body and improve treatment effectiveness for cancer patients.

The lab led by Dr. Benjamin Wildman-Tobriner focuses on improving the management of thyroid nodules using advanced imaging techniques and artificial intelligence. The main goal of the research is to reduce unnecessary biopsies and treatments for low-risk thyroid cancers by developing criteria that emphasize patient outcomes rather than merely diagnosing cancer. By integrating machine learning with ultrasound imaging, the lab aims to enhance diagnostic accuracy and ultimately lower healthcare costs.

Dr. Zhen Xu's lab at the University of Michigan focuses on innovative ways to treat soft tissue sarcomas, which are challenging tumors to manage due to their size and location near critical structures. They are developing a new ultrasound-based system that can safely and effectively destroy these tumors without the need for surgery. This research aims to enhance patient outcomes by creating non-invasive treatment options that can potentially benefit both humans and animals.

Professor Jun Chen's lab at UCLA is focused on creating innovative vascular grafts that can continuously monitor blood flow and detect issues like stenosis without invasive procedures. They are developing a new type of graft that uses advanced materials to wirelessly transmit health data in real-time, which can help improve patient outcomes after surgeries. The lab combines expertise in bioengineering, tissue engineering, and artificial intelligence to address significant challenges in vascular health management.

Dr. Sridhar Nimmagadda's lab focuses on improving the diagnosis and treatment of blood cancers like multiple myeloma and lung cancer through innovative theranostic approaches. They aim to create advanced imaging agents and targeted therapies that can effectively measure and combat cancer while reducing the need for invasive procedures. By developing new, easy-to-use radiopharmaceuticals, the lab seeks to enhance the precision of immunotherapy treatments and improve patient outcomes.

Dr. Jeff W. Bulte's lab at Johns Hopkins University focuses on improving cancer treatments through advanced imaging technologies. By using magnetic iron oxide nanoparticles (MIONPs), the lab works on coordinating imaging with magnetic fluid hyperthermia (MFH) to enhance the effectiveness of radiation therapy for cancer patients. The goal is to develop methods that allow precise control of heat applied to tumors while monitoring the treatment in real-time, which could lead to better outcomes for patients.

Dr. Mitra Aliabouzar's lab focuses on developing advanced imaging techniques to better understand thrombus (blood clot) characteristics over time. By using ultrasound-responsive nanodroplets, the lab aims to create a non-invasive method that can provide real-time information about thrombus age and mechanical properties, enhancing treatment strategies for conditions like cardiovascular disease. This innovative approach has the potential to significantly improve patient outcomes by enabling timely and tailored treatments for thrombus-related complications.

Dr. Kyriacos A. Athanasiou's lab at UC Irvine focuses on developing innovative treatments for injuries related to the temporomandibular joint (TMJ). They are exploring the use of engineered tissue implants, specifically neodisc constructs, that incorporate immune cells to enhance healing and reduce rejection by the body. This multidisciplinary approach aims to solve a pressing medical issue affecting millions and could lead to advancements in tissue engineering beyond TMJ applications.

Dr. Gelsy Torres-Oviedo's lab at the University of Pittsburgh focuses on understanding how cognitive factors influence walking, especially in older adults at risk for Alzheimer's Disease. They investigate how gait—the way we walk—changes when our brains need to pay attention, and how this might indicate risks for cognitive decline. By studying the underlying brain mechanisms involved, the lab aims to improve early detection of Alzheimer's and related conditions.

Dr. Natalia A. Trayanova's lab focuses on advancing strategies for diagnosing and treating heart rhythm disorders using innovative technologies like digital twins and artificial intelligence. By understanding how conditions like obesity affect heart health and arrhythmias, the lab aims to develop personalized approaches to improve therapies for patients suffering from ventricular arrhythmias and atrial fibrillation. Their work bridges computational modeling with clinical applications, making strides towards more effective treatments and interventions.

Dr. Peter Glazer's lab focuses on finding ways to treat cancer by targeting specific weaknesses in tumor DNA repair processes. They study how certain mutations can make tumors more vulnerable to treatments that exploit these weaknesses. The lab combines basic science research with clinical trials to develop innovative therapies, including unique antibody treatments and small molecule drug combinations, aimed at improving outcomes for cancer patients.

Dr. Lauren Colbert's lab focuses on understanding the role of specific bacteria, particularly Lactobacillus iners, in cervical cancer. The lab investigates how these bacteria influence cancer cell behavior and patient outcomes, aiming to develop new therapies that target the tumor microbiome. This research is especially important for improving treatment options for underserved populations affected by cervical cancer.

Professor Guillem Pratx's lab at Stanford University focuses on developing advanced tumor models that closely mimic real human cancer tissues. By using innovative technologies like microfluidics and radioluminescence microscopy, the lab aims to create personalized models of tumors from patients, which can be used for drug discovery and to improve cancer treatment. Their research is designed to enhance the capability of imaging these models, making it possible to evaluate new therapies in a way that may lead to better patient outcomes.

Dr. Laura D. Attardi's lab focuses on understanding how the p53 gene helps suppress cancer. By studying its pathways and interactions, the lab aims to identify potential new treatments for various cancers like lung adenocarcinoma and hepatocellular carcinoma. The research uses advanced techniques like CRISPR and single-cell sequencing to gain insights into cancer biology and improve therapeutic strategies.

Dr. Jason Bini's research lab at Yale University focuses on understanding type 1 diabetes, particularly how it affects insulin production in the body. The lab uses advanced imaging techniques like PET and MRI to study changes in the pancreas, including how well insulin-producing cells are functioning. By tracking these changes over time, the lab aims to improve treatment strategies for individuals at risk or newly diagnosed with type 1 diabetes, ultimately enhancing their quality of life.

Dr. Kamil Ugurbil's lab at the University of Minnesota focuses on understanding how different parts of the brain connect and communicate with each other. By mapping these connections in detail, they aim to uncover the underlying mechanisms that support behaviors and cognitive functions, such as decision-making and attention. Their innovative approach combines advanced imaging techniques and anatomical studies on both human and nonhuman primate brains.

Dr. Emil Schueler's research lab focuses on improving cancer treatment through innovative radiation therapies. By investigating ultra-high dose rate radiotherapy, also known as FLASH radiotherapy, the lab aims to enhance tumor control while minimizing damage to surrounding healthy tissues. This work could transform standard radiation therapy, making it safer and more effective for cancer patients.

Dr. Paul Dayton's lab focuses on developing advanced ultrasound imaging technologies that can provide high-resolution images of blood vessels, particularly in relation to cancer detection. The lab has created unique devices that allow for improved visualization of microvascular structures, which are crucial for identifying cancerous tissues. Their innovative approach aims to make these imaging techniques applicable to clinical settings, providing better tools for early cancer diagnosis.

Dr. Oliver D. Kripfgans' lab focuses on improving dental implant surgery by using ultrasound imaging to monitor healing after dental bone grafts. The research aims to replace traditional 2D and 3D radiographs, which expose patients to radiation, with a non-invasive ultrasound method that can provide detailed images over time. This innovative approach seeks to enhance patient outcomes and refine surgical practices in implant dentistry.